stockTargetAdvisor

Under-perform

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 8.36

+0.01 (+0.12)%

USD 35.24B

2.12M

USD 0.00(+0.00%)

USD 11.00 (+31.58%)

Icon

BAYRY

Bayer AG PK (USD)
COMMON STOCK | OTC
USD 8.36
0.00 0
Take a Tour
stockTargetAdvisor

Under-perform

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 35.24B

USD 11.00 (+31.58%)

USD 8.36

Bayer AG PK Stock Forecast

Show ratings and price targets of :
N/A
(+0.00%)

Based on the Bayer AG PK stock forecast from 3 analysts, the average analyst target price for Bayer AG PK is not available over the next 12 months. Bayer AG PK’s average analyst rating is Under-perform. Stock Target Advisor’s own stock analysis of Bayer AG PK is Slightly Bullish , which is based on 10 positive signals and 5 negative signals. At the last closing, Bayer AG PK’s stock price was USD 8.36. Bayer AG PK’s stock price has changed by -6.28% over the past week, -21.50% over the past month and -42.50% over the last year.

No recent analyst target price found for Bayer AG PK
No recent average analyst rating found for Bayer AG PK

Company Overview Bayer AG PK

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health...Read More

https://www.bayer.com

Kaiser-Wilhelm-Allee 1, Leverkusen, Germany, 51368

100,873

December

USD

USA

Adjusted Closing Price for Bayer AG PK (BAYRY)

Loading...

Unadjusted Closing Price for Bayer AG PK (BAYRY)

Loading...

Share Trading Volume for Bayer AG PK Shares

Loading...

Compare Performance of Bayer AG PK Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BAYRY

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bayer AG PK (Sector: Drug Manufacturers-General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GLAXD
GSK plc 0.00 (0.00%) USD76.42B 12.75 8.92

ETFs Containing BAYRY

Symbol Name BAYRY's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Bayer AG PK (BAYRY) Stock

Based on ratings from 3 analysts Bayer AG PK's stock is Under-perform. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has buy, 1 sell and 3 hold ratings.

BAYRY stock's dividend yield is 7.41%. Our analysis grades BAYRY stock's dividend yield at A+. This means that BAYRY stock's dividend yield is above 100% of the stocks in the Drug Manufacturers-General sector in the OTC exchange. Based on this BAYRY may be a good dividend stock for its sector.

Based on targets from 3 analysts, the average taret price for BAYRY is USD 0.00 over the next 12 months. The maximum analyst target price is USD while the minimum anlayst target price is USD .

BAYRY stock's Price/Earning ratio is 28.91. Our analysis grades BAYRY stock's Price / Earning ratio at A+. This means that BAYRY stock's Price/Earning ratio is above 0% of the stocks in the Drug Manufacturers-General sector in the OTC exchange. Based on this BAYRY may be undervalued for its sector.

The last closing price of BAYRY's stock was USD 8.36.

The most recent market capitalization for BAYRY is USD 35.24B.

Based on targets from 3 analysts, the average taret price for BAYRY is projected at USD 0.00 over the next 12 months. This means that BAYRY's stock price may go up by +0.00% over the next 12 months.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...